Firefly Neuroscience Inc(AIFF) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 13 at 4:00 PM ET (Korea 11/14 06:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.49 | Insider Own | 9.23% | Shs Outstand | 15.8M | Perf Week | 2.72% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 14.3M | Perf Month | -15% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 9.92% | Short Float | 3.87% | Perf Quarter | -17.26% |
| Income | -0.01B | P/S | 7.15 | EPS this Y | - | Inst Trans | 3.22% | Short Ratio | 0.21 | Perf Half Y | -45% |
| Sales | 0.00B | P/B | 1.1 | EPS next 5Y | - | ROA | -59.42% | Short Interest | 0.55M | Perf YTD | 6.86% |
| Book/sh | 0.85 | P/C | 1.84 | EPS past 3/5Y | 59.7% - | ROE | -71.7% | 52W High | -70.32% ($3.15) | Perf Year | -41.56% |
| Cash/sh | 0.51 | P/FCF | - | Sales past 3/5Y | -53.03% -39.34% | ROIC | -61.63% | 52W Low | 51.42% ($0.62) | Perf 3Y | -76.57% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 80.71% | Gross Margin | 54.86% | Volatility(W/M) | 6.92% 7.6% | Perf 5Y | -99.02% |
| Dividend TTM | - | EV/Sales | 3.26 | Sales Y/Y TTM | 162.84% | Oper. Margin | -385.23% | ATR (14) | 0.09 | Perf 10Y | -79.24% |
| Dividend Ex-Date | - | Quick Ratio | 4.45 | EPS Q/Q | 64.91% | Profit Margin | -402.14% | RSI (14) | 42.52 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.48 | Sales Q/Q | 66.75% | SMA20 | -5.36% ($0.99) | Beta | 0.47 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -17.62% ($1.14) | Rel Volume | 0.02 | Prev Close | $0.96 |
| Employees | 17 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -31.56% ($1.37) | Avg Volume(3M) | 2.62M | Price | $0.94 |
| IPO | 1994/4/6 | Option/Short | No/Yes | Trades | 190 | Volume | 64,549 | Change | -2.97% |
🧠 This is a US-based AI brain analytics company that provides BNA (Brain Network Analytics), an FDA 510(k)-cleared platform that uses AI to analyze EEG and event-related potential (ERP) data to help diagnose neuropsychiatric and neurological conditions such as depression, dementia, and ADHD.
Over the past 1 year, on the lower side
70% below its 1-year high.
Traded less than usual. That is 2% of its average volume.
AIFF has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $715. Peers typically go for $136.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -99.0%. The S&P 500 did +61% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 9.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
IWC iShares Micro-Cap ETF <0.01% 
VXF Vanguard Extended Market Index ETF <0.01% It ranks #187 of 223 in the industry
Based on market cap of $15M.
IPM#186 Intelligent Protection Management Corp $16M PER - AIFF#187 Firefly Neuroscience Inc $15M PER - 
IDAI#188 T Stamp Inc $15M PER - 
SMSI#189 Smith Micro Software Inc $14M PER - 
BMR#190 Beamr Imaging Ltd $14M PER - 
FAQ
What kind of company is AIFF?
AIFF belongs to the Technology sector and operates in the Software - Application industry.
What is the market cap of AIFF?
The market cap of AIFF is approximately $15M, ranking 5,267 within its sector.
What is the 52-week high and low for AIFF?
AIFF has recorded a 52-week high of $3.15 and a low of $0.62.
